Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers

被引:11
|
作者
Kim, Woo Jung [1 ,2 ]
Lee, Sang Don [3 ]
Lee, Eun [2 ,4 ,5 ]
Namkoong, Kee [2 ,4 ]
Choe, Kang-Won [6 ]
Song, Joon Young [7 ]
Cheong, Hee Jin [7 ]
Jeong, Hye Won [8 ]
Heo, Jung Yeon [8 ]
机构
[1] Eulji Univ, Eulji Addict Inst, Gangnam Eulji Hosp, Dept Psychiat, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea
[3] Armed Forces Capital Hosp, Dept Psychiat, Songnam, Gyeonggi, South Korea
[4] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea
[5] Severance Hosp, Sleep Hlth Ctr, Seoul, South Korea
[6] Armed Forces Capital Hosp, Dept Internal Med, Songnam, Gyeonggi, South Korea
[7] Korea Univ Coll Med, Dept Internal Med, Seoul, South Korea
[8] Chungbuk Natl Univ, Dept Internal Med, Cheongju, Chungbuk, South Korea
关键词
Narcolepsy; Incidence; H1N1 influenza A; Vaccination; Adjuvants; MF59; AUTOIMMUNE-DISEASE; ASSOCIATION; INFECTIONS; VACCINES;
D O I
10.1016/j.vaccine.2015.07.055
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Previous reports mostly from Europe suggested an association between an occurrence of narcolepsy and an influenza A(H1N1)pdm09 vaccine adjuvanted with AS03 (Pandemrix (R)). During the 2009 H1N1 pandemic vaccination campaign, the Korean military performed a vaccination campaign with one type of influenza vaccine containing MF59-adjuvants. This study was conducted to investigate the background incidence rate of narcolepsy in South Korean soldiers and the association of the MF59-adjuvanted vaccine with the occurrence of narcolepsy in a young adult group. Methods: To assess the incidence of narcolepsy, we retrospectively reviewed medical records of suspicious cases of narcolepsy in 2007-2013 in the whole 20 military hospitals of the Korean military. The screened cases were classified according to the Brighton Collaboration case definition of narcolepsy. After obtaining the number of confirmed cases of narcolepsy per 3 months in 2007-2013, we compared the crude incidence rate of narcolepsy before and after the vaccination campaign. Results: We included 218 narcolepsy suspicious cases in the initial review, which were screened by the diagnostic code on the computerized disease registry in 2007-2013. Forty-one cases were finally diagnosed with narcolepsy in 2007-2013 (male sex, 95%; median age, 21 years). The average background incidence rate of narcolepsy in Korean soldiers was 0.91 cases per 100,000 persons per year. During the 9 months before vaccination implementation (April to December 2009), 6 narcolepsy cases occurred, whereas during the next 9 months (January to September 2010) including the 3-month vaccination campaign, 5 cases occurred. Conclusions: The incidence of narcolepsy in South Korean soldiers was not increased after the pandemic vaccination campaign using the MF59-adjuvanted vaccine. Our results suggest that the MF59-adjuvanted H1N1 vaccine did not contribute to the occurrence of narcolepsy in this young adult group. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4868 / 4872
页数:5
相关论文
共 50 条
  • [1] The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
    Wijnans, Leonoor
    Lecomte, Coralie
    de Vries, Corinne
    Weibel, Daniel
    Sammon, Cormac
    Hviid, Anders
    Svanstrom, Henrik
    Molgaard-Nielsen, Ditte
    Heijbel, Harald
    Dahlstrom, Lisen Arnheim
    Hallgreng, Jonas
    Sparen, Par
    Jennum, Poul
    Mosseveld, Mees
    Schuemie, Martijn
    van der Maas, Nicoline
    Partinen, Markku
    Romio, Silvana
    Trotta, Francesco
    Santuccio, Carmela
    Menna, Angelo
    Plazzi, Giuseppe
    Moghadam, Keivan Kaveh
    Ferro, Salvatore
    Lammers, Gert Jan
    Overeem, Sebastiaan
    Johansen, Kari
    Kramarz, Piotr
    Bonhoeffer, Jan
    Sturkenboom, Miriam C. J. M.
    VACCINE, 2013, 31 (08) : 1246 - 1254
  • [2] Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
    Wijnans, Leonoor
    Dieleman, Jeanne
    Voordouw, Bettie
    Sturkenboom, Miriam
    PLOS ONE, 2013, 8 (04):
  • [3] No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: An ecological study
    Choe, Young June
    Bae, Geun-Ryang
    Lee, Duk-hyoung
    VACCINE, 2012, 30 (52) : 7439 - 7442
  • [4] Fetal Safety of an Adjuvanted Influenza A(H1N1)pdm09 Vaccine
    Molgaard-Nielsen, Ditte
    Pasternak, Bjorn
    Svanstrom, Henrik
    Krause, Tyra G.
    Emborg, Hanne-Dorthe
    Melbye, Mads
    Hviid, Anders
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 392 - 392
  • [5] Incidence of narcolepsy before and after the pandemic influenza a (H1N1) vaccination in the Korean military
    Kim, W.
    Lee, S.
    Lee, E.
    Namkoong, K.
    Choe, K.
    Song, J.
    Cheong, H.
    Jeong, H.
    Heo, J.
    SLEEP MEDICINE, 2015, 16 : S165 - S165
  • [6] Narcolepsy and A(H1N1)pdm09 vaccination Shaping the research on the observed signal
    van der Most, Robbert
    Van Mechelen, Marcelle
    Destexhe, Eric
    Wettendorff, Martine
    Hanon, Emmanuel
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (03) : 572 - 576
  • [7] Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe
    Mereckiene, J.
    Cotter, S.
    Weber, J. T.
    Nicoll, A.
    D'Ancona, F.
    Lopalco, P. L.
    Johansen, K.
    Wasley, A. M.
    Jorgensen, P.
    Levy-Bruhl, D.
    Giambi, C.
    Stefanoff, P.
    Dematte, L.
    O'Flanagan, D.
    EUROSURVEILLANCE, 2012, 17 (04) : 18 - 27
  • [8] No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination
    Lamb, Favelle
    Ploner, Alexander
    Fink, Katharina
    Maeurer, Markus
    Bergman, Peter
    Piehl, Fredrik
    Weibel, Daniel
    Sparen, Par
    Arnheim-Dahlstrom, Lisen
    PLOS ONE, 2016, 11 (04):
  • [9] Pandemic Influenza A(H1N1)pdm09 Seroprevalence in Sweden before and after the Pandemic and the Vaccination Campaign in 2009
    Morner, Andreas
    Brave, Andreas
    Kling, Anna-Maria
    Kuhlmann-Berenzon, Sharon
    Krook, Katarina
    Hedenskog, Mona
    Silhammar, Irene
    Ljungman, Margaretha
    Ortqvist, Ake
    Andersson, Soren
    Brytting, Maria
    Thorstensson, Rigmor
    Linde, Annika
    PLOS ONE, 2012, 7 (12):
  • [10] Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine.
    Clark, Tristan W.
    Pareek, Manish
    Hoschler, Katja
    Dillon, Helen
    Nicholson, Karl G.
    Groth, Nicola
    Stephenson, Iain
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25): : 2424 - 2435